These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 30641417)
21. BCL2 Inhibitor (ABT-737): A Restorer of Prednisolone Sensitivity in Early T-Cell Precursor-Acute Lymphoblastic Leukemia with High MEF2C Expression? Kawashima-Goto S; Imamura T; Tomoyasu C; Yano M; Yoshida H; Fujiki A; Tamura S; Osone S; Ishida H; Morimoto A; Kuroda H; Hosoi H PLoS One; 2015; 10(7):e0132926. PubMed ID: 26172269 [TBL] [Abstract][Full Text] [Related]
22. Clinicopathological and immunophenotypic features of early T cell precursor acute lymphoblastic leukaemia: A flow cytometry score for the initial diagnosis. Chandra D; Singh MK; Gupta R; Rahman K; Yadav DD; Sarkar MK; Gupta A; Yadav S; Kashyap R; Nityanand S Int J Lab Hematol; 2021 Dec; 43(6):1417-1423. PubMed ID: 34115925 [TBL] [Abstract][Full Text] [Related]
23. [Identification of Differentially Expressed Gene Core Genes in Early T-Cell Precursor Acute Lymphoblastic Leukemia and Its Regulatory Network Analysis]. Lun YZ; Sun J; Yu ZG Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):673-684. PubMed ID: 31204916 [TBL] [Abstract][Full Text] [Related]
24. Short-course Venetoclax With Standard Chemotherapy Is Effective in Early T-cell Precursor Acute Lymphoblastic Leukemia. Borah P; Dayal N; Pathak S; Naithani R J Pediatr Hematol Oncol; 2023 Jul; 45(5):271-274. PubMed ID: 37027330 [TBL] [Abstract][Full Text] [Related]
25. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia]. Lu XT Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360 [TBL] [Abstract][Full Text] [Related]
26. Early T-Cell Precursor Leukemia Has a Higher Risk of Induction-Related Infection among T-Cell Acute Lymphoblastic Leukemia in Adult. Huang K; Dai M; Li Q; Liu N; Lin D; Wang Q; Zhou X; Wang Z; Gao Y; Jin H; Liu X; Liu Q; Zhou H Mediators Inflamm; 2020; 2020():8867760. PubMed ID: 33424437 [TBL] [Abstract][Full Text] [Related]
27. Clinical features, laboratory characteristics, and outcome of ETP and TCRA/D aberrations in pediatric patients with T-acute lymphoblastic leukemia. Ashry MSE; Radwan E; Abdellateif MS; Arafah O; Hassan NM J Egypt Natl Canc Inst; 2023 Jun; 35(1):17. PubMed ID: 37303010 [TBL] [Abstract][Full Text] [Related]
28. Early T-cell precursor acute lymphoblastic leukemia with Tran T; Krause J Proc (Bayl Univ Med Cent); 2018 Oct; 31(4):511-513. PubMed ID: 30948995 [TBL] [Abstract][Full Text] [Related]
29. A Novel Case of Concurrent T-cell and Early T-cell Precursor Lymphoblastic Lymphoma in an Adolescent Female. Treinen C; Abu-Arja MH; Kahwash SB; Rangarajan HG; Willen F; Audino AN J Pediatr Hematol Oncol; 2022 Mar; 44(2):e550-e553. PubMed ID: 34310470 [TBL] [Abstract][Full Text] [Related]
30. Predicting response to BET inhibitors using computational modeling: A BEAT AML project study. Drusbosky LM; Vidva R; Gera S; Lakshminarayana AV; Shyamasundar VP; Agrawal AK; Talawdekar A; Abbasi T; Vali S; Tognon CE; Kurtz SE; Tyner JW; McWeeney SK; Druker BJ; Cogle CR Leuk Res; 2019 Feb; 77():42-50. PubMed ID: 30642575 [TBL] [Abstract][Full Text] [Related]
31. T-cell transcription factor GATA-3 is an immunophenotypic marker of acute leukemias with T-cell differentiation. Dorfman DM; Morgan EA; Pelton A; Unitt C Hum Pathol; 2017 Jul; 65():166-174. PubMed ID: 28551327 [TBL] [Abstract][Full Text] [Related]
32. MEF2C-dysregulated pediatric T-cell acute lymphoblastic leukemia is associated with CDKN1B deletions and a poor response to glucocorticoid therapy. Colomer-Lahiguera S; Pisecker M; König M; Nebral K; Pickl WF; Kauer MO; Haas OA; Ullmann R; Attarbaschi A; Dworzak MN; Strehl S Leuk Lymphoma; 2017 Dec; 58(12):2895-2904. PubMed ID: 28482719 [TBL] [Abstract][Full Text] [Related]
33. Intracellular Cholesterol Pools Regulate Oncogenic Signaling and Epigenetic Circuitries in Early T-cell Precursor Acute Lymphoblastic Leukemia. Rashkovan M; Albero R; Gianni F; Perez-Duran P; Miller HI; Mackey AL; Paietta EM; Tallman MS; Rowe JM; Litzow MR; Wiernik PH; Luger S; Sulis ML; Soni RK; Ferrando AA Cancer Discov; 2022 Mar; 12(3):856-871. PubMed ID: 34711640 [TBL] [Abstract][Full Text] [Related]
35. [Immunophenotypic Analysis of Patients with Adult Acute T-Lymphoblastic Leukemia]. Lin N; Liu ZH; Wang PP; Fu W; Yan XJ; Li Y Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):442-445. PubMed ID: 32319376 [TBL] [Abstract][Full Text] [Related]
36. Multi-omic approaches to improve outcome for T-cell acute lymphoblastic leukemia patients. van der Zwet JCG; Cordo' V; Canté-Barrett K; Meijerink JPP Adv Biol Regul; 2019 Dec; 74():100647. PubMed ID: 31523030 [TBL] [Abstract][Full Text] [Related]
37. Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15. Inukai T; Kiyokawa N; Campana D; Coustan-Smith E; Kikuchi A; Kobayashi M; Takahashi H; Koh K; Manabe A; Kumagai M; Ikuta K; Hayashi Y; Tsuchida M; Sugita K; Ohara A Br J Haematol; 2012 Feb; 156(3):358-65. PubMed ID: 22128890 [TBL] [Abstract][Full Text] [Related]
38. Early T-Cell Precursor Acute Lymphoblastic Leukemia: Diagnosis, Updates in Molecular Pathogenesis, Management, and Novel Therapies. Sin CF; Man PM Front Oncol; 2021; 11():750789. PubMed ID: 34912707 [TBL] [Abstract][Full Text] [Related]
39. Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma. Berlow NE; Rikhi R; Geltzeiler M; Abraham J; Svalina MN; Davis LE; Wise E; Mancini M; Noujaim J; Mansoor A; Quist MJ; Matlock KL; Goros MW; Hernandez BS; Doung YC; Thway K; Tsukahara T; Nishio J; Huang ET; Airhart S; Bult CJ; Gandour-Edwards R; Maki RG; Jones RL; Michalek JE; Milovancev M; Ghosh S; Pal R; Keller C BMC Cancer; 2019 Jun; 19(1):593. PubMed ID: 31208434 [TBL] [Abstract][Full Text] [Related]
40. Peripheral blood flow cytometry for the diagnosis of pediatric acute leukemia: Highly reliable with rare exceptions. Cheng J; Klairmont MM; Choi JK Pediatr Blood Cancer; 2019 Jan; 66(1):e27453. PubMed ID: 30255571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]